BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
05 Oct 2023
Historique:
received: 06 06 2023
medline: 5 10 2023
pubmed: 5 10 2023
entrez: 5 10 2023
Statut: aheadofprint

Résumé

Not available.

Identifiants

pubmed: 37794811
doi: 10.3324/haematol.2023.283684
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Francesco Malfona (F)

Hematology, Department of Translational and Precision Medicine, Sapienza University.

Ilaria Tanasi (I)

Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona.

Matteo Piccini (M)

SOD Ematologia, Università Di Firenze, AOU Careggi, Firenze.

Cristina Papayannidis (C)

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna.

Vincenzo Federico (V)

Hematology and Transplant Unit, Vito Fazzi Hospital, Lecce.

Valentina Mancini (V)

ASST Grande Ospedale Metropolitano Niguarda, Milano.

Elisa Roncoroni (E)

Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia.

Elisabetta Todisco (E)

IEO, European Institute of Oncology IRCCS, Milan.

Simona Bianchi (S)

Hematology, Department of Translational and Precision Medicine, Sapienza University.

Giulia Ciotti (G)

Onco Hematology, Department of Oncology-Veneto Institute of Oncology IOV-IRCCS, Padua.

Patrizia Chiusolo (P)

Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore.

Massimo Gentile (M)

Hematology Unit AO of Cosenza, Cosenza, Italy; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende.

Valentina Gianfelici (V)

Department Hematology-Oncology- Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro.

Fabio Giglio (F)

Haematology and BMT Unit, IRCCS San Raffaele Scientific Institute, Milan.

Michele Malagola (M)

Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, "ASST-Spedali Civili" Hospital of Brescia, Department of Clinical and Experimental Sciences, University of Brescia, Brescia.

Antonino Mulé (A)

Division of Onco-Hematology, AO Ospedali Riuniti Villa Sofia-Cervello, Palermo.

Francesco Saraceni (F)

Hematology and Stem Cell Transplant, Ancona University Hospital.

Calogero Vetro (C)

Hematology and BMT Unit, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico-San Marco", Catania.

Francesco Zallio (F)

Hematology Department, SS Antonio and Biagio and C. Arrigo Hospital, Alessandria.

Luca Vincenzo Cappelli (LV)

Hematology, Department of Translational and Precision Medicine, Sapienza University.

Giovanni Pizzolo (G)

Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona.

Robin Foà (R)

Hematology, Department of Translational and Precision Medicine, Sapienza University.

Massimiliano Bonifacio (M)

Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona.

Sabina Chiaretti (S)

Hematology, Department of Translational and Precision Medicine, Sapienza University. chiaretti@bce.uniroma1.it.

Classifications MeSH